riends of Cancer Research (Friends) is proud to announce our next hybrid meeting, The Next Generation of Cellular Therapies: A Blueprint to Accelerate Development, the second in a two-meeting series focusing on cell and gene therapies.

This meeting will bring together experts in the field in-person to present development strategies and policy proposals that can facilitate rapid development, commercialization and evolution of safe and effect T-cell based immunotherapies, such as CAR-T cell therapies and other engineered T-cell therapies. Following up on our March virtual meeting which focused on exploring and presenting opportunities in the field, this meeting’s white paper and panel discussions will facilitate development of the next generation of immunotherapies and support current policy discussions between key stakeholders in drug development

This meeting builds on Friends’  previous work on Cell & Gene Therapies, and is the second of two meetings in 2023 to explore next steps in the field. Click Here for more information about the first meeting in this series, which took place on March 8th, 2023.

Register for in-person or virtual attendance above and please stay tuned for more information.